Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Sponsored Content | Blog | Greg Freiherr, Industry Consultant | PET-CT | October 25, 2018

Digital PET Balances Scan Time and Resolution

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the detector built into Philips Healthcare’s digital Vereos PET/CT.

Because photons generated during a PET exam are counted individually, digital detectors can record more such events per second than analog ones.

The University of Vermont Medical Center (UVMC) often leverages this on its Vereos to produce images with very high quality. Alternatively, UVMC uses Vereos to shorten scan time while still producing diagnostic quality images.

“When there is a big leap in sensitivity like you see from analog to digital, you have to look at what you are going to do with it,” said Jay Kikut, M.D., director of nuclear medicine and PET/CT at the UVMC. “For oncology patients, our decision is clear — we want to use it for improved image quality.”

This is paramount when clinicians use Vereos to make diagnoses and stage cancer patients. “Vereos provides us very accurate staging of our patients,” he said. “To have the best outcome, you have to match the treatments to the stage.” Exactly staging patients leads to a more individualized choice of therapy.

The 1 mm thick images reveal details in this PET/CT whole-brain volume acquired during a five-minute scan on the Vereos PET/CT. Images courtesy of Philips Healthcare.

 

Oncological applications account for about 80 percent of PET scans done at UVMC. (The remaining 20 percent of PET/CTs examine the heart or brain.) 

When set to deliver maximum spatial resolution, the increased sensitivity achieved through digital PET is used to detect very small lesions. Alternatively, some patients at UVMC are best served by scans that minimize time spent inside the PET/CT bore. Such shorter exams might be chosen for children or patients who are uncomfortable in tight spaces to minimize the movement that can cause image artifacts.

Although the scans may be substantially shorter — five or even three minutes versus the 15 needed with an analog detector — Vereos’ PET acquisitions can still deliver high diagnostic quality, he said.

Development of the Digital Photon Counting (DPC) technology, which serves as Vereos’ backbone, is the latest pivotal moment in the history of PET/CT, according to Dhruv Mehta, a senior product manager at Philips Healthcare. The first occurred some 20 years ago with the hybridization of PET with CT. The second was the development of time-of-flight (introduced first-to-market by Philips Healthcare), which helps localize lesions and improves signal-to-noise. Fully digital PET with DPC technology is the latest advancement affecting this hybrid, Mehta said.

“It is really the next generation of PET/CT,” he said.

The difference between digital and analog PET is akin to the difference between projection and LCD televisions. The digital architecture of LCD TVs, he said, delivers a sharper image, higher efficiency and more dynamic range. Digital PET does much the same in molecular imaging. This linkage between image quality and dynamic range is important, Mehta said, when trying to go beyond the current FDG-based oncology applications into emerging applications in neurology and cardiology and emerging tracers.

“With a shorter acquisition, the patient is less likely to move,” he said. “The clinical benefit is that you have a better study with less motion. As a result, you can visualize lesions better.”

The other aspect of efficiency is increased throughput. In the U.S., PET patient volumes typically hover around a dozen or so patients per day. In Europe or China, however, daily throughput may exceed 30.

Mehta cautions that many factors beyond the scanner may affect throughput at a facility. Chief among them are ones related to patient management. Cutting scan time to under five minutes, however, “is a substantial improvement.”

Very relevant when making purchasing decisions, he said, is the increased precision that digital PET offers and the hedge that Vereos provides against obsolescence. At present, PET is one of the few commercial modalities with high-end systems that are still analog, he said. That, however, could change.

“We envision a time in the future when all PET/CT is digital,” Mehta said.

 

Editor's note: This is the third blog in a series of four on digital PET/CT. The first blog, “How Digital PET/CT Can Improve Clinical Care,” can be found here. The second blog, “Why - And How - Digital PET Is Better Than Analog,” can be found here.

 

Related Content:

SPECIAL SUPPLEMENT: Examining the Value of Digital PET/CT

Related Content

Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
News | SPECT Imaging | September 30, 2020
September 30, 2020 — Siemens Healthineers h
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020
September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated
A 12-year-long collaboration with Canon Medical Research USA, Canon Medical Systems Japan and Southern Nevada outpatient radiology leader Steinberg Diagnostic Medical Imaging (SDMI) has resulted in the development of 3 PET scanners, each generation more advanced than the last
News | PET-CT | September 08, 2020
September 8, 2020 — A 12-year-long collaboration with...
a) Includes scintigraphy and PET with and without concomitant CT. b) Includes conventional radiography, dual-energy x-ray absorptiometry, fluoroscopy, and radiography performed during radiologic interventions. c) Includes general, cardiothoracic, maxillary, plastic, and orthopedic surgery and neurosurgery. d) Includes allergology, cardiology, geriatrics, general internal medicine, pulmonology, gastroenterology, and rheumatology

a) Includes scintigraphy and PET with and without concomitant CT. b) Includes conventional radiography, dual-energy x-ray absorptiometry, fluoroscopy, and radiography performed during radiologic interventions. c) Includes general, cardiothoracic, maxillary, plastic, and orthopedic surgery and neurosurgery. d) Includes allergology, cardiology, geriatrics, general internal medicine, pulmonology, gastroenterology, and rheumatology. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Radiology Imaging | August 14, 2020
August 14, 2020 — According to ARRS' ...
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...